Company Active LTD

Company profile

Ingenza Limited

Home - Ingenza

Ingenza Limited is a UK company with status active founded in 2002 based in Scotland.

CRN
SC237393
Founded
2002
Age
23

Overview

Legal name
INGENZA LIMITED
Region
Scotland
Registered address
INGENZA LIMITED
MOUBRAY BUILDING
EDINBURGH TECHNOPOLE
MILTON BRIDGE
SCOTLAND
EH26 0GB
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Ingenza Limited
CRN SC237393
2
Direct and ultimate controller Active LTD
Ingenza Holdings Ltd
CRN SC776676

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
47

Company events

Reference milestones and recent Companies House filing stream events.

12 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

10 Oct
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

09 Jun
2026

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzUyNTkwNTQ4MWFkaXF6a2N4

Published 09 Jun 2026 06:40

08 Jun
2026

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzUyNTg4Nzg5MWFkaXF6a2N4

Published 08 Jun 2026 11:31

08 Jun
2026

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzUyNTg4NzU0MGFkaXF6a2N4

Published 08 Jun 2026 11:28

08 Jun
2026

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzUyNTg4NjQ4MmFkaXF6a2N4

Published 08 Jun 2026 11:22

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

26 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

29 Oct
2024

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzQ0MTI0MzA2NGFkaXF6a2N4

Published 29 Oct 2024 11:54

27 Sep
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzNzUzMDE2OGFkaXF6a2N4

Published 27 Sep 2024 12:55

24 Sep
2024

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzQzNzAwMDQzMmFkaXF6a2N4

Published 24 Sep 2024 11:52

26 Sep
2002

Incorporated

Inception

Company registered at Companies House

Public funding

47 awards
First funded
2005
Funded years
2005, 2007, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2024, 2025
Age at first award
3 years

Projects

2025 Collaborative R&D Lead participant

SMARTY: Sustainable Methacrylate Advanced Research Technology for Yeast

1 Sep 2025 to 28 Feb 2027

Awarded
£134,042
Total cost £191,488

Project lead, Ingenza Ltd. will apply cutting edge engineering biology to advance the commercial utility of a non-conventional yeast with properties very suited to industrial use (e.g. rapid growth, feedstock versatility, high product tolerance) but severely lacking to date in the methods and genetic tools necessary for effective biotechnology application...

2024 Launchpad Lead participant

codABLE: Data-driven optimised protein production using Pichia pastoris

1 Apr 2024 to 31 Mar 2025

Awarded
£99,883
Total cost £126,595

Our project addresses the critical need for viable, sustainable biomanufacturing processes and accelerated development of protein therapeutics, emphasising the importance of predictability when designing DNA sequences to produce valuable heterologous proteins efficiently, using recombinant organisms. Leveraging insights from natural codon usage profiles, ...

2024 Collaborative R&D

Topical bacteriocin therapy with epidermicin NI01 for dermatological infections (TOBRADERM)

1 Jan 2024 to 31 Dec 2025

Awarded
£134,022
Total cost £191,460

Amprologix is a company developing novel antibiotics to meet the global threat of antimicrobial resistance (AMR). AMR happens when bacteria become resistant to antibiotics and results in treatment failure and increased death from 'drug resistant' infections. These infections killed over 1.2 million people in 2019 and new antibiotics are urgently needed. I...

2022 EU-Funded Lead participant

BIOS: The bio-intelligent DBTL cycle, a key enabler catalysing the industrial transformation towards sustainable biomanufacturing

1 Oct 2022 to 30 Sep 2026

Awarded
£510,566
Total cost £510,566

no public description

2021 Collaborative R&D Lead participant

Unleashing Putida: Biobased Methacrylates for a Sustainable Future

1 Mar 2021 to 31 May 2023

Awarded
£454,525
Total cost £649,322

This project will apply world-class biotechnology to deliver the world's first bio-based commercially viable manufacturing process for methacrylate ester (MAE), the building block of poly-methylmethacrylate (Perspex(r)) with a game-changing improvement in sustainability. The collaboration of Mitsubishi Chemical Corporation (MCC --Japan), Lucite Internatio...

2020 Collaborative R&D Lead participant

High-performance yeast for sustainable liquid fuel

1 Oct 2020 to 30 Jun 2021

Awarded
£172,537
Total cost £215,671

Carbon utilisation in bioethanol production by the yeast _Saccharomyces_ _cerevisiae_ suffers significant efficiency losses because the organism also produces glycerol as a (waste) co-product to help maintain its osmotic balance. This low value waste product compromises bioethanol yield by up to 5%. Others have tried to address this problem, employing yea...

2020 Small Business Research Initiative Lead participant

HydroGreen Biofuel: Reducing the carbon footprint of highly efficient bioethanol production

1 Oct 2020 to 31 Dec 2020

Awarded
£59,767
Total cost £59,767

This project will have a disruptive impact on the sustainability and cost effectiveness of ethanol production for the renewable fuels sector, while improving the environmental footprint and climate-change impact of the entire ethanol industry. It will address multiple economic, social, environmental and political needs. It will achieve this through innova...

2020 Study

Investigating the mechanistic pathways of augmented volatile organic compounds related to the oesophagogastric cancer microbiome

1 Oct 2020 to 31 Jul 2021

Awarded
£0
Total cost £0

Oesophagogastric cancer (cancer of the food pipe and stomach) is the fifth most common cancer in England and Wales with 16,000 new cases diagnosed every year. Currently only 15 out of every 100 patients diagnosed with this type of cancer live beyond 5 years. When oesophagogastric cancer is detected it is often in an advanced late stage. This is because sy...

2020 Feasibility Studies Lead participant

A novel bio-manufacturing platform to accelerate and to increase industrial use of cold-active enzymes

1 Jun 2020 to 30 Nov 2020

Awarded
£34,348
Total cost £34,348

no public description

2020 Feasibility Studies Lead participant

Recombinant yeast production of COVID-19 antigen to support clinical testing

1 May 2020 to 28 Feb 2021

Awarded
£72,425
Total cost £72,425

This project aims to support a novel and vital alternative strategy to realise broad population immunity to the SARS-CoV-2 virus (the cause of COVID-19 disease) in the event that the adenoviral-based vaccines currently under development in the UK prove insufficiently efficacious, safe and/or cost-effective. It will show that yeast-based production of a ke...

2019 Collaborative R&D Lead participant

Enzyme-enhanced safe placement of paediatric nasogastric feeding tubes

1 Jul 2019 to 31 Dec 2020

Awarded
£109,477
Total cost £156,396

This project aims to demonstrate the significant safety and cost benefits of a novel enzyme-enhanced test-strip that rapidly substantiates the correct placement of nasogastric feeding tube in infants and neonates - patient sub-groups for which tube placement errors confer very significant clinical risks and costs. Several hundred thousand nasogastric (NG)...

2018 Collaborative R&D

A novel biomanufacturing platform to accelerate and to increase industrial use of cold-active enzymes

1 Apr 2018 to 31 Dec 2020

Awarded
£350,200
Total cost £500,285

"Bio-inspired processes will have a major impact on the challenges of the global society in 21st century, including those associated with environmental sustainability. The employment of biocatalysts in industrial processes is expected to boost a sustainable production of chemicals, materials and fuels from renewable resources. The scope of this proposal i...

Product types

BIS-Funded Programmes Centres Collaborative R&D EU-Funded Feasibility Studies GRD Proof of Market Launchpad Small Business Research Initiative Study